- Trials with a EudraCT protocol (12)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
12 result(s) found for: Neonatal Hypoxic Ischemic Encephalopathy.
Displaying page 1 of 1.
EudraCT Number: 2015-003063-12 | Sponsor Protocol Number: NEU-01-02-1A | Start Date*: 2016-09-14 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Neurophyxia B.V. | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: TIBC study: A multiple-centre Phase 2 trial comparing the efficacy of 2-Iminobiotin (2-IB) treatment to standard care in neonates with gestational age of ≥36 weeks with moderate to severe perinatal... | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Perinatal asphyxia | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005796-18 | Sponsor Protocol Number: 03-217 | Start Date*: 2009-07-21 | ||||||||||||||||
Sponsor Name:WKZ / UMC Utrecht | ||||||||||||||||||
Full Title: Does antenatal allopurinol during asphyxia reduce post-hypoxic-ischemic reperfusion damage in the newborn? | ||||||||||||||||||
Medical condition: Perinatal asphyxia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: In utero, Preterm newborn infants, Newborns, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005696-17 | Sponsor Protocol Number: 1645-CI-058 | Start Date*: 2013-06-18 |
Sponsor Name:Instituto de Investigacion Sanitaria La Fe | ||
Full Title: Multicenter, randomized, blinded clinical study comparing early use of total body moderate hypothermia plus topiramate or placebo in asphyxiated newborn infants evolving to moderate-to-severe hypox... | ||
Medical condition: Asphyxiated newborn infants evolving to moderate-to-severe hypoxic ischemic encephalopathy | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000222-19 | Sponsor Protocol Number: H2020-PHC-18-2015-667224 | Start Date*: 2017-08-02 | ||||||||||||||||
Sponsor Name:University Hospital Tuebingen | ||||||||||||||||||
Full Title: Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome – a blinded randomized placebo-controlled parallel group multicenter trial for superiori... | ||||||||||||||||||
Medical condition: Perinatal Asphyxia, hypoxic-ischemic brain injury | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) NL (Ongoing) NO (Ongoing) ES (Ongoing) FI (Ongoing) EE (Ongoing) AT (Ongoing) BE (Ongoing) PT (Ongoing) IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000936-17 | Sponsor Protocol Number: GWEP1560 | Start Date*: 2019-07-23 | ||||||||||||||||
Sponsor Name:GW Research Ltd | ||||||||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Single-Ascending Dose Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of GWP42003-P in Conjunction with Hypothermia in Neonates with ... | ||||||||||||||||||
Medical condition: Neonatal Hypoxic-Ischemic Encephalopathy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-020797-41 | Sponsor Protocol Number: NEMO1-08NR26 | Start Date*: 2010-11-16 | |||||||||||
Sponsor Name:Only for Children Pharmaceuticals | |||||||||||||
Full Title: NEMO-1: An open label exploratory dose finding and pharmacokinetic clinical trial of bumetanide for the treatment of NEonatal seizure using Medication Off-patent. | |||||||||||||
Medical condition: Neonatal Seizures in Hypoxic Ischemic Encephalopathy | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) FI (Prematurely Ended) GB (Prematurely Ended) SE (Prematurely Ended) FR (Ongoing) NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001826-13 | Sponsor Protocol Number: 200721 | Start Date*: 2015-02-16 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Limited | |||||||||||||
Full Title: Randomized, Double-blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban Therapy for Women in Spontaneous Preterm Labor | |||||||||||||
Medical condition: preterm labor | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) SE (Completed) ES (Completed) DE (Completed) IT (Prematurely Ended) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004596-31 | Sponsor Protocol Number: NL62772 | Start Date*: 2019-03-25 | ||||||||||||||||
Sponsor Name:UMC Utrecht | ||||||||||||||||||
Full Title: CeRebrUm and CardIac protection with Allopurinol in neonates with critical congenital heart disease requiring cardiac surgery with cardiopulmonary bypass | ||||||||||||||||||
Medical condition: Brain injury in neonates with critical congenital heart disease requiring cardiac surgery with cardiopulmonary bypass. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Newborns, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000770-29 | Sponsor Protocol Number: Ireland-RctV8 | Start Date*: 2018-06-18 | ||||||||||||||||
Sponsor Name:The Rotunda Hospital | ||||||||||||||||||
Full Title: Investigating the role of early low-dose aspirin in diabetes: A phase III multicentre double-blinded placebo-controlled randomised trial of low-dose aspirin initiated in the first trimester of diab... | ||||||||||||||||||
Medical condition: Pregestational type I or type II diabetes | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: IE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-000622-22 | Sponsor Protocol Number: ASAP | Start Date*: 2012-07-20 | |||||||||||
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | |||||||||||||
Full Title: Aspirin for the enhancement of trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14 weeks of gestation | |||||||||||||
Medical condition: Placental insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000456-15 | Sponsor Protocol Number: 3518 | Start Date*: 2015-05-19 | |||||||||||
Sponsor Name:Kings College London [...] | |||||||||||||
Full Title: The prevention of pre-term birth in women who develop a short cervix. A multi-centre randomised controlled trial to compare three treatments; cervical cerclage, cervical pessary and vaginal proges... | |||||||||||||
Medical condition: Short Cervix in Pregnancy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003326-41 | Sponsor Protocol Number: 200719 | Start Date*: 2016-01-13 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Limited | |||||||||||||
Full Title: Randomized, Double-Blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of Retosiban Versus Placebo for Women in Spontaneous Preterm Labor | |||||||||||||
Medical condition: Preterm Labour | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.